Cargando…

Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis

INTRODUCTION: Pulmonary exacerbations (PEx) in persons with cystic fibrosis (CF) are primarily related to acute or chronic inflammation associated with bacterial lung infections, which may be caused by several bacteria that activate similar bacterial genes and produce similar by-products. The goal o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shumyatsky, Gabriella, Burrell, Aszia, Chaney, Hollis, Sami, Iman, Koumbourlis, Anastassios C., Freishtat, Robert J., Crandall, Keith A., Zemanick, Edith T., Hahn, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868313/ https://www.ncbi.nlm.nih.gov/pubmed/36698799 http://dx.doi.org/10.3389/fmed.2022.1082125

Ejemplares similares

Importance of beta-lactam pharmacokinetics and pharmacodynamics on the recovery of microbial diversity in the airway of persons with cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2021)

Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2023)

Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity
por: Hahn, Andrea, et al.
Publicado: (2018)

Impact of Antibiotics on the Lung Microbiome and Lung Function in Children With Cystic Fibrosis 1 Year After Hospitalization for an Initial Pulmonary Exacerbation
por: Inam, Zaina, et al.
Publicado: (2022)

Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation
por: Hahn, Andrea, et al.
Publicado: (2020)

Inflammation in children with cystic fibrosis: contribution of bacterial production of long-chain fatty acids
por: Felton, Erin, et al.
Publicado: (2021)

2573. Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Lung Microbiome Diversity and Pulmonary Function
por: Jason. Bozzella, Michael, et al.
Publicado: (2019)

Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome Diversity
por: Hahn, Andrea, et al.
Publicado: (2018)

Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2019)

Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study
por: Hahn, Andrea, et al.
Publicado: (2020)

Bacteriophage Therapy for Pan-Drug-Resistant Pseudomonas aeruginosa in Two Persons With Cystic Fibrosis
por: Hahn, Andrea, et al.
Publicado: (2023)

Measuring the impact of an empiric antibiotic algorithm for pulmonary exacerbation in children and young adults with cystic fibrosis
por: Kennedy, Charles, et al.
Publicado: (2022)

Fungal Infection and Inflammation in Cystic Fibrosis
por: Poore, T. Spencer, et al.
Publicado: (2021)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis
por: Johnson, Emily J., et al.
Publicado: (2016)

Infection, Allergy, and Inflammation: The Role of Aspergillus fumigatus in Cystic Fibrosis
por: Poore, T. Spencer, et al.
Publicado: (2023)

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing
por: Hoppe, Jordana E., et al.
Publicado: (2022)

Unraveling the CFTR Function–Phenotype Connection for Precision Treatment in Cystic Fibrosis
por: Zemanick, Edith T., et al.
Publicado: (2019)

Reliability of Quantitative Real-Time PCR for Bacterial Detection in Cystic Fibrosis Airway Specimens
por: Zemanick, Edith T., et al.
Publicado: (2010)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis
por: Laguna, Theresa A., et al.
Publicado: (2016)

Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis
por: Vieira, Jacob, et al.
Publicado: (2022)

Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome
por: Sibley, Christopher D., et al.
Publicado: (2011)

An Overview on the Upper and Lower Airway Microbiome in Cystic Fibrosis Patients
por: Meskini, Maryam, et al.
Publicado: (2021)

A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome
por: Woo, T. E., et al.
Publicado: (2019)

Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
por: Yi, Buqing, et al.
Publicado: (2021)

Intestinal Lesions Are Associated with Altered Intestinal Microbiome and Are More Frequent in Children and Young Adults with Cystic Fibrosis and Cirrhosis
por: Flass, Thomas, et al.
Publicado: (2015)

2578. Trends in Pathogens and Antibiotic Treatment in Children with Cystic Fibrosis in 2018 and 2022: A Retrospective Multicenter Study
por: Stout, Dayna, et al.
Publicado: (2023)

Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis()
por: Hoppe, Jordana E., et al.
Publicado: (2018)

Highlights from the 2016 North American Cystic Fibrosis Conference
por: Zemanick, Edith T., et al.
Publicado: (2017)

The Microbiome in Cystic Fibrosis
por: Huang, Yvonne J., et al.
Publicado: (2016)

Nasopharyngeal Microbiome Diversity Changes over Time in Children with Asthma
por: Pérez-Losada, Marcos, et al.
Publicado: (2017)

AtbFinder Diagnostic Test System Improves Optimal Selection of Antibiotic Therapy in Persons with Cystic Fibrosis
por: Tetz, G., et al.
Publicado: (2023)

Cholesteryl Esters Are Elevated in the Lipid Fraction of Bronchoalveolar Lavage Fluid Collected from Pediatric Cystic Fibrosis Patients
por: Ma, Daniel C., et al.
Publicado: (2015)

Airway Clearance Therapy in Cystic Fibrosis Patients Insights from a Clinician Providing Cystic Fibrosis Care
por: Chaudary, Nauman, et al.
Publicado: (2021)

Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis
por: Hoppe, Jordana E., et al.
Publicado: (2017)

Change in circulating proteins during treatment of pulmonary exacerbation in patients with cystic fibrosis
por: Wagner, Brandie D., et al.
Publicado: (2021)

Clinical characteristics of people with cystic fibrosis and frequent fungal infection
por: Poore, T. Spencer, et al.
Publicado: (2021)

Commensal Bacteria in the Cystic Fibrosis Airway Microbiome Reduce P. aeruginosa Induced Inflammation
por: Tony-Odigie, Andrew, et al.
Publicado: (2022)

Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of Pseudomonas aeruginosa
por: Reece, Emma, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7v055g6aj5kh8ecf2otaop1qcg